Drug Profile
Research programme: monoclonal antibody 1F7 - Immune Network/InNexus Biotechnology
Alternative Names: 1F7Latest Information Update: 04 May 2007
Price :
$50
*
At a glance
- Originator Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Developer Immune Network; InNexus Biotechnology
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections